Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01488747 · ClinicalTrials.gov registry record · NA

Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride

A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT01488747 is a NA study that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01488747, a NA study, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The primary objective of this investigation is to determine the relative percentage and rate of incorporation of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and total omega-3 (n-3) fatty acids after ingestion of 4 emulsified flavored triglyceride fish oil supplements versus an encapsulated triglyceride in defined plasma lipid pools. The primary endpoints to be evaluated include the fatty acid composition of plasma lipids before and after consumption of a single dose of emulsified triglyceride based fish oil and triglyceride of similar n-3 compositions in capsule form. The investigators will measure changes in plasma phospholipid, and chylomicron fatty acids.

Interventions

  • DIETARY_SUPPLEMENT Coromega Omega-3 Squeeze
  • DIETARY_SUPPLEMENT Coromega Nectar
  • DIETARY_SUPPLEMENT Barleans Swirl
  • DIETARY_SUPPLEMENT Nordic Omega-3 Softgel

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2011-11
Est. Completion 2016-04
Phase NA

What the Registry Record Tells You About NCT01488747

The ClinicalTrials.gov registry entry for NCT01488747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA Grand Forks Human Nutrition Research Center, which has 57 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Coromega Omega-3 Squeeze is the first listed.

NCT01488747 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01488747 about?

NCT01488747 is a clinical study titled "Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride". The primary objective of this investigation is to determine the relative percentage and rate of incorporation of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and total omega-3 (n-3) fatty acids after ingestion of 4 emulsified flavored triglyceride fish oil supplements versus an encapsulat...

What is the current status of trial NCT01488747?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2011-11. Estimated completion is 2016-04.

What interventions are being tested in trial NCT01488747?

The interventions under investigation include: Coromega Omega-3 Squeeze (DIETARY_SUPPLEMENT), Coromega Nectar (DIETARY_SUPPLEMENT), Barleans Swirl (DIETARY_SUPPLEMENT), Nordic Omega-3 Softgel (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01488747?

This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.